Portland, OR -- (SBWIRE) -- 03/01/2018 -- In vitro is the process that helps examine harmful chemicals over the isolated part of the organism. It is used to identify hazardous chemical substances and helps detect the toxicity at early stages of the development of new products such as drugs, cosmetics, and food additives. The in vitro toxicity testing is mainly used for safety evaluation in drug development and also for ranking the chemicals according to their potency. The absorption, distribution, metabolism, excretion (ADME), dose response, threshold response of drug can also be determined by the in vitro toxicity testing.

The global in vitro toxicity testing market is expected to witness notable growth during the analysis period due to the increase in number of R&D procedures, which require in vitro testing, ban on animal testing, and increase in awareness about the environmental concerns. In addition, advancement in genetics and genetic screening approaches and emergence of new approaches of 3D cell culture can boost the in vitro toxicity testing market. The large size companies have focused on new product launch to meet the specific requirements of the researchers.

Get the PDF of In Vitro Toxicity Testing industry insights @ https://www.alliedmarketresearch.com/request-sample/1523

The report analyzes the in vitro toxicity testing market into three segments, namely: type, end users, and geography. By type, the market is segmented into absorption, toxic substances, and dose. Based on end users, the market is categorized into cosmetic and household products, pharmaceutical industry, food industry, and chemical industry. Based on geography, the in vitro toxicity testing market is categorized into North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this report include Agilent Technologies, Inc., BioReliance, Inc., Alere, Inc., Charles River Laboratories International, Inc., General Electric Company, Covance, Inc., Catalent, Inc., Eurofins Scientific, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific, Inc. There are other players in the in vitro toxicity testing market, which include Cyprotex plc, Accelrys, Inc., Molecular Toxicology Inc., MatTek Corporation, Xenometrix AG, and Quest Diagnostics Incorporation.

Do purchase inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1523

IN VITRO TOXICITY TESTING MARKET KEY BENEFITS:

- The report provides an extensive analysis of the current trends and highlights the market potential from 2014 to 2022, in terms of value.
- The market scenario is comprehensively analyzed with respect to the type and end users.
- Comprehensive analysis of the patents is provided to determine the prevailing opportunities.
- Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
- In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.

IN VITRO TOXICITY TESTING MARKET KEY SEGMENTS

The global in vitro toxicity testing market segmentation is explained below:

By Type

- Absorption
- Toxic Substances
- Dose

By End users

- Cosmetics and Household Products
- Pharmaceutical Industry
- Food Industry
- Chemical Industry